Mario Mandala (@mandalamario) 's Twitter Profile
Mario Mandala

@mandalamario

Associate professor of Medical Oncology

ID: 1038017732

linkhttp://www.unipg.it calendar_today26-12-2012 20:37:47

206 Tweet

277 Followers

260 Following

Titus J. Brinker, MD (@titusbrinker) 's Twitter Profile Photo

Productive meeting with key European players in #childhood, adolescent and young adult #melanoma in Rome as part of the #EU #MELCAYA project. Together, we collect unique data informing better diagnoses and treatment decisions for young patients!🇪🇺🏥@dkfz

Productive meeting with key European players in #childhood, adolescent and young adult #melanoma in Rome as part of the #EU #MELCAYA project. Together, we collect unique data informing better diagnoses and treatment decisions for young patients!🇪🇺🏥@dkfz
Mario Mandala (@mandalamario) 's Twitter Profile Photo

A great conversation I had with Dr Teresa Amaral, MD, PhD on the @EMJ Podcast “Navigating Adjuvant Melanoma Treatment Choices”, discussing the typical patient for whom adjuvant therapy may be considered, and provide details on therapy choices. Listen here: emjreviews.com/dermatology/po….

Mario Mandala (@mandalamario) 's Twitter Profile Photo

Sinner, Binaghi: "Le critiche a Jannik dai più cretini e frustrati" | Gazzetta.it Mi sembra che questo commento sia eloquente. Forza ⁦⁦Jannik Sinner⁩ orgoglio italiano gazzetta.it/Tennis/21-08-2…

Mario Mandala (@mandalamario) 's Twitter Profile Photo

Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study). Great collaboration and impactful results showing that anti PD1 are effective and well tolerated in pediatric melanoma population even < 12 years pubmed.ncbi.nlm.nih.gov/39236557/

Mario Mandala (@mandalamario) 's Twitter Profile Photo

Statins to prevent anthracycline-related myocardial toxicity: The jury is still out. pubmed.ncbi.nlm.nih.gov/38852023/ Are statins ready for prime time to prevent anthracyclime-related toxicity? Read our recent editorial on this important topic

Mario Mandala (@mandalamario) 's Twitter Profile Photo

Understanding timing of SRS and immunotherapy: the right study for the right question in patients with brain metastases from melanoma or non-small cell lung cancer – The ETOP 19-21 USZ-STRIKE study - Lung Cancer lungcancerjournal.info/article/S0169-…

Mario Mandala (@mandalamario) 's Twitter Profile Photo

Adjuvant pembrolizumab did not have a significant impact on long-term HRQOL compared with placebo in patients with resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): long-term, health-related quality-of-life results thelancet.com/journals/lanon…

Mario Mandala (@mandalamario) 's Twitter Profile Photo

Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: an international retrospective study - European Journal of Cancer ejcancer.com/article/S0959-…

Fondazione Aiom (@aiomfondazione) 's Twitter Profile Photo

Martedì 15 luglio alle 17 vi aspettiamo su #AIOMtv per parlare di eccessiva esposizione al #sole e #prevenzione. Link alla diretta: youtube.com/live/abszi3p4H… #fondazioneaiom #oncologia #cancro

Martedì 15 luglio alle 17 vi aspettiamo su #AIOMtv per parlare di eccessiva esposizione al #sole e #prevenzione. 

Link alla diretta: youtube.com/live/abszi3p4H…

#fondazioneaiom #oncologia #cancro
Via Medica (@viamedica_pl) 's Twitter Profile Photo

📢 Warsaw Skin Cancer Conference 2025 📅 3–4.10.2025 | 📍 Warszawa Pod kierunkiem prof. Piotra Rutkowskiego o czerniaku, nowych terapiach i wyzwaniach w leczeniu nowotworów skóry 👉 wsc.viamedica.pl #melanoma #onkologia #WarsawSkinCancer2025

📢 Warsaw Skin Cancer Conference 2025
📅 3–4.10.2025 | 📍 Warszawa
Pod kierunkiem prof. Piotra Rutkowskiego o czerniaku, nowych terapiach i wyzwaniach w leczeniu nowotworów skóry
👉 wsc.viamedica.pl
#melanoma #onkologia #WarsawSkinCancer2025
Mario Mandala (@mandalamario) 's Twitter Profile Photo

Clinical validation of droplet digital PCR assays in detecting BRAFV600-mutant circulating tumour DNA as a prognostic biomarker in patients with resected stage III melanoma receiving adjuvant therapy (COMBI-AD): a biomarker analysis from a randomised study pubmed.ncbi.nlm.nih.gov/40250457/

Mario Mandala (@mandalamario) 's Twitter Profile Photo

Immunotherapy or targeted therapy with or without stereotactic radiosurgery for patients with brain metastases from melanoma or non-small cell lung cancer - The ETOP 19-21 USZ-STRIKE study - PubMed pubmed.ncbi.nlm.nih.gov/39731865/

Mario Mandala (@mandalamario) 's Twitter Profile Photo

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2024 - PubMed pubmed.ncbi.nlm.nih.gov/39709737/

Mario Mandala (@mandalamario) 's Twitter Profile Photo

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2024 - PubMed pubmed.ncbi.nlm.nih.gov/39700658/

Mario Mandala (@mandalamario) 's Twitter Profile Photo

Incidence and prognosis of cutaneous melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results - PubMed pubmed.ncbi.nlm.nih.gov/39546860/

Mario Mandala (@mandalamario) 's Twitter Profile Photo

Statins to prevent anthracycline-related myocardial toxicity: The jury is still out - PubMed pubmed.ncbi.nlm.nih.gov/38852023/